AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway

被引:59
作者
Gorina, R
Petegnief, V
Chamorro, A
Planas, AM
机构
[1] IDIBAPS, IIBB, CSIC, Dept Farmacol & Toxicol, Barcelona 08036, Spain
[2] IDIBAPS, Hosp Clin, Inst Malalties Neurol, Barcelona, Spain
关键词
antioxidant; interferon-gamma; interleukin-6; interleukin-10; Stat1; Stat3;
D O I
10.1111/j.1471-4159.2004.02878.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Janus kinases/STAT pathway mediates cellular responses to certain oxidative stress stimuli and cytokines. Here we examine the activation of Stat1 and Stat3 in rat astrocyte cultures and its involvement in cell death. H2O2, interferon (INF)-gamma and interleukin (IL)-6 but not IL-10 caused cell death. Stat1 was phosphorylated on tyrosine (Tyr)-701 after exposure to H2O2, INF-gamma or IL-6 but not IL-10. Tyr-705 pStat3 was observed after H2O2, IL-6 and IL-10. Also, H2O2 induced serine (Ser)-727 phosphorylation of Stat1 but not Stat3. The degree of Tyr-701 pStat1 by the different treatments positively correlated with the corresponding reduction of cell viability. AG490, a Jak2 inhibitor, prevented Tyr-701 but not Ser-727, Stat1 phosphorylation. Also, AG490 inhibited Tyr-705 Stat3 phosphorylation induced by H2O2 and IL-6 but did not prevent that induced by IL-10. Furthermore, AG490 conferred strong protection against cell death induced by INF-gamma, IL-6 and H2O2. These results suggest that Jak2/Stat1 activation mediates cell death induced by proinflammatory cytokines and peroxides. However, we found evidence suggesting that AG490 reduces oxidative stress induced by H2O2, which further shows that H2O2 and/or derived reactive oxygen species directly activate Jak2/Stat1, but masks the actual involvement of this pathway in H2O2-induced cell death.
引用
收藏
页码:505 / 518
页数:14
相关论文
共 93 条
[1]  
Aloisi F, 1997, J IMMUNOL, V159, P1604
[2]   INTERLEUKIN-6 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE STROKE [J].
BEAMER, NB ;
COULL, BM ;
CLARK, WM ;
HAZEL, JS ;
SILBERGER, JR .
ANNALS OF NEUROLOGY, 1995, 37 (06) :800-805
[3]   Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice [J].
Bolin, LM ;
Strycharska-Orczyk, I ;
Murray, R ;
Langston, JW ;
Di Monte, D .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (01) :167-175
[4]   Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury [J].
Bolli, R ;
Dawn, B ;
Xuan, YT .
TRENDS IN CARDIOVASCULAR MEDICINE, 2003, 13 (02) :72-79
[5]   Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress [J].
Boyd, ZS ;
Kriatchko, A ;
Yang, JJ ;
Agarwal, N ;
Wax, MB ;
Patil, RV .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (12) :5206-5211
[6]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[7]   Reactive oxygen radicals in signaling and damage in the ischemic brain [J].
Chan, PH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (01) :2-14
[8]   Thyrotropin modulates interferon-γ-mediated intercellular adhesion molecule-1 gene expression by inhibiting Janus kinase-1 and signal transducer and activator of transcription-1 activation in thyroid cells [J].
Chung, J ;
Park, ES ;
Kim, D ;
Suh, JM ;
Chung, HK ;
Kim, J ;
Kim, H ;
Park, SJ ;
Kwon, OY ;
Ro, HK ;
Shong, M .
ENDOCRINOLOGY, 2000, 141 (06) :2090-2097
[9]   STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation [J].
Chung, JK ;
Uchida, E ;
Grammer, TC ;
Blenis, J .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6508-6516
[10]   Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway [J].
Darnell, JE .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (08) :549-554